Skip to main content
. 2017 Mar 13;143(7):1167–1176. doi: 10.1007/s00432-017-2372-z

Table 2.

Results of the multiple binary logistic regression analysis modelling the probability of being at least in the medium adherent group

Response: “at least medium adherence” Reference category or increment Full model
(n = 2358; 490 low adherence)
Final model
(n = 2491; 520 low adherence)
OR 95% CI for OR p OR 95% CI for OR p
Age per year 1.043 1.033–1.052 <0.0001 1.045 1.036–1.054 <0.0001
Sex Female 1.385 1.120–1.712 0.0026 1.389 1.130–1.707 0.0018
Living with someoone No 1.381 1.030–1.851 0.0310 1.345 1.005–1.773 0.0400
Chronic phase No 1.796 0.999–1.130 0.0502
Years since diagnosis <2 0.386 0.272–0.547 <0.0001 0.324 0.239–0.438 <0.0001
Management of side effects Not well managed (vs none or well managed) 1.348 1.054–1.723 0.0174 1.299 1.023–1.649 0.0321
Doses >one 1.979 1.569–2.496 <0.0001 1.888 1.520–2.344 <0.0001
Other medications No 1.282 1.023–1.607 0.0310 1.255 1.007–1.565 0.0433
Time on current medication <6 months (vs 6 months to 3 years) 0.712 0.436–1.103 0.1255
<6 months (vs more than 3 years) 0.693 0.436–1.103 0.1220
Personal payment obligations <50 EUR 1.611 1.098–2.364 0.0147 1.616 1.112–2.349 0.0119
Use of reminding tools No 1.040 0.808–1.340 0.7593
Informed about risks No 0.934 0.750–1.163 0.5412
Satisfied with information on CML 4 stages from ‘not at all’ to ‘very’ 1.278 1.105–1.508 0.0026 1.279 1.097–1.492 0.0017